Información del producto
- (3β,6α,12β)-20-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl)-β-<smallcap>D</span>-glucopyranoside
- 2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid
- 2-O-(6-deoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranoside
- 2-O-(6-desoxi-α-L-manopiranosil)-(3β,6α,12β)-20-(β-D-glucopiranosiloxi)-3,12-dihidroxidamar-24-en-6-il-β-D-glucopiranosido
- 2-O-(6-desoxy-α-L-mannopyrannosyl)-(3β,6α,12β)-20-(β-D-glucopyrannosyloxy)-3,12-dihydroxydammar-24-ene-6-yl-β-D-glucopyrannoside
- Chikusetsusaponin IVc
- Ginsenoside B2
- Ginsenoside B<sub>2</sub>
- Notoginsenoside Re
- Nsc 308877
- Ver más sinónimos
- Panaxoside Re
- Re ginsenoside
- Sanchinoside Re
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,6α,12β)-20-(β-<smallcap>D</smallcap>-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-<smallcap>L</span>-mannopyranosyl)-
- 2-O-(6-Deoxy-alpha-L-mannopyranosyl)-(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-beta-D-glucopyranoside
- (3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
- (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- Ginsenoside
- β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-
- (3beta,6alpha,9xi,12beta,13alpha)-20-[(3xi)-beta-D-ribo-hexopyranosyloxy]-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 20-(hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxyhexopyranosyl)hexopyranoside
Ginsenoside Re, a main phytosterol of Panax ginseng, inhibits Ca(2+) accumulation in mitochondria during cardiac ischemia/reperfusion, which is attributable to nitric oxide (NO)-induced Ca(2+) channel inhibition and K(+) channel activation in cardiac myocytes, acts as a specific agonist for the nongenomic pathway of sex steroid receptors, and NO released from activated eNOS underlies cardiac K(+) channel activation and protection against ischemia-reperfusion injury, G-Re also exerts antiischemic effect and induces angiogenic regeneration.[1,2]
Propiedades químicas
Consulta técnica sobre: BP-BP0662 Ginsenoside Re
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.